Literature DB >> 16722133

An audit of the quality of endometrial cancer care in a specialised unit.

D E Parkin1, Q Warraich, D J Fleming, G K Chew, M E Cruickshank.   

Abstract

BACKGROUND: Endometrial cancer is the 5th most common female cancer in Scotland and though cure rates are good, 25% of women still die of their disease. Staging has been shown to be poorly performed in Scotland-wide audit and inadequate staging is a predictor of worse outcome. Only 12% of women with endometrial cancer in Scotland are operated upon by a specialist gynaecological oncologist. AIMS: To determine if the quality of staging information in endometrial cancer is improved in a region where all cases are managed by specialist gynaecological oncologists.
METHODS: All 108 women diagnosed and treated with endometrial cancer in Grampian in 2002 and 2003 had a retrospective case note assessment of the completeness of staging information. This was compared to previously published Scottish results.
RESULTS: Completeness of staging was high. The International Federation of Gynecology and Obstetrics (FIGO) stage was available in 100% of women. Chest X Ray was performed in 85% and peritoneal cytology in 93%. Pelvic lymphadenectomy was performed in 28%. All these results were significantly better than in the Scottish audit.
CONCLUSION: Centralisation of women with endometrial cancer results in accurate staging information. However it is not yet known what effect this may have on outcome.

Entities:  

Mesh:

Year:  2006        PMID: 16722133     DOI: 10.1258/RSMSMJ.51.2.22

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  1 in total

Review 1.  Should Endometrial Cancer Treatment Be Centralized?

Authors:  Vincenzo Dario Mandato; Andrea Palicelli; Federica Torricelli; Valentina Mastrofilippo; Chiara Leone; Vittoria Dicarlo; Alessandro Tafuni; Giacomo Santandrea; Gianluca Annunziata; Matteo Generali; Debora Pirillo; Gino Ciarlini; Lorenzo Aguzzoli
Journal:  Biology (Basel)       Date:  2022-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.